HOW SUPPLIED: Production is supplied in 10-mL, multidose vials containing 0.5 mg of dexmedetomidine hydrochloride per mL.

INDICATIONS: Dexmedetomidine hydrochloride is indicated for use as a sedative and analgesic in dogs and cats to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. Dexmedetomidine hydrochloride is also indicated for use as a preanesthetic to general anesthesia in dogs and cats.

Dexmedetomidine hydrochloride is a highly specific α2 adrenergic receptor stimulant, which mainly reduces sympathetic nerve activity, produces sedation and analgesic effects, and the depth and process of these effects are related to the concentration of the drug. Dexmedetomidine has a significant synergistic effect on other central inhibitors, such as anesthetics, and is able to significantly reduce the dose of anesthetics.

Only be used for scientific research, not for humans and animals.